(Total Views: 707)
Posted On: 03/31/2021 1:19:03 PM
Post# of 158220
Yes, this 14 day data in the the 3/30/2021 press release convinced me to buy more. I think it's a perfectly simple and powerful statement of trial data that medical professionals, the public, and investors should notice. I believe it brings up an enormous ethics issue for the FDA who has had all the raw trial data for many weeks since this was an endpoint in a pre-defined group.
The simple headline of the press release is a great opener for the notes I've sent to friends and family. I'll make it even shorter-
***Leronlimab decreased mortality by 82% in Critically Ill COVID-19 patients***
https://www.cytodyn.com/newsroom/press-releas...14-days-by
The simple headline of the press release is a great opener for the notes I've sent to friends and family. I'll make it even shorter-
***Leronlimab decreased mortality by 82% in Critically Ill COVID-19 patients***
https://www.cytodyn.com/newsroom/press-releas...14-days-by
(7)
(0)
There are no guarantees in investing. No one should consider these pages or posts to be financial advice. Everyone has a responsibility to verify and thoroughly learn more than what is referenced or written here, and everyone must take responsibility for their own investing decisions.
